Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification

Urology

Volumn 53, Issue 2, 1999, Pages 322-328

  D'Ancona, F C H ^a   Van Der Bij, A K ^a   Francisca, E A E ^a   Kho, H ^a   Debruyne, F M J ^a   Kiemeney, L A ^a   De La Rosette, J J M C H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANESTHESIOLOGY; DIATHERMY; HUMANS; MALE; MICROWAVES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0032923004     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00502-0     Document Type: Article

References (22)

1. Meigs J.B., Barry M.J. Natural history of benign prostatic hyperplasia. Kirby R.S., McConnell J.D., Fitzpatrick J.M., et al. Textbook of Benign Prostatic Hyperplasia. 1996;125-135 Isis Medical Media, Oxford.
2. Transurethral prostatectomy: immediate and postoperative complications. A co-operative study of 13 participating institutions evaluating 3885 patients. J Urol. 141:1989;243-247.
3. Christensen M.M., Bruskewitz R.C. Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention. Urol Clin North Am. 17:1990;509-516.
4. Nielsen K.K., Nordling J. Urethral stricture following transurethral prostatectomy. Urology. 35:1990;18-24.
5. Fowler F.J. Jr, Wennberg J.E., Timothy R.P., et al. Symptom status and quality of life following prostatectomy. JAMA. 259:1988;3018-3022.
6. Evans J.W.H., MacCartney N. The complications of prostatectomy. Chapple C.R. Prostatic Obstruction Pathogenesis and Treatment . 1994;113-145 Springer-Verlag, London.
7. Pedersen T. Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors. Dan Med Bull. 41:1994;319-331.
8. Menke H., Klein A., John K.D., et al. Predictive value of ASA-classification for the assessment of perioperative risk. Int Surg. 78:1993;266-270.
9. Schaltz G., Madersbacher S., Lang T., et al. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives. J Urol. 158:1997;105-111.
10. Matani Y., Mottrie A.M., Stöckle M., et al. Transurethral prostatectomy A long-term follow-up study of 166 patients over 80 years of age . Eur Urol. 30:1996;414-417.
11. Ross A.F., Tinken J.H. Pharmacology of intravenous nonnarcotic anesthetics. Miller R.D. Anesthesia. 1994;809-810 Churchill Livingstone, New York.
12. de la Rosette J.J.M.C.H., Debruyne F.M.J. Transurethral thermotherapy. Puppo P. Contemporary BPH Management. 1993;77-86 Monduzzi Editors, Bologna.
13. Aso Y., Abbou C.C., Abrams P., et al. Clinical research criteria. Cockett A.T.K., Aso Y., Chatelain C., et al. The Third International Consultation on Benign Prostatic Hyperplasia (BPH). 1995;451-468 Scientific Communication International Ltd, Paris.
14. Schäfer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol. 13:1995;47-58.
15. de la Rosette J.J.M.C.H., Tubaro A., Höfner K., et al. Transurethral microwave thermotherapy: past, present and future. World J Urol. 12:1994;352-356.
16. d'Ancona FCH, Francisca EAE, Hendriks JCM, et al: The predictive value of baseline parameters in the treatment of benign prostatic hyperplasia using high energy transurethral microwave thermotherapy. Br J Urol (in press).
17. d'Ancona F.C.H., Francisca E.A.E., Hendriks J.C.M., et al. How to select patients for high-energy transurethral microwave thermotherapy? Urology. 53:1999;111-117.
18. de Wildt M.J.A.M., Tubaro A., Höfner K., et al. Responders and non-responders to transurethral microwave thermotherapy a multicenter retrospective analysis . J Urol. 154:1995;1775-1778.
19. Berg C., Choi N., Colombeau P., et al. Responders versus non-responders to thermotherapy in BPH a multicenter retrospective analysis of patient and treatment profiles . J Urol. 149:1993;251A.
20. Arai Y., Fukuwaza S., Terai A., et al. Transurethral microwave thermotherapy for benign prostatic hyperplasia relation between clinical response and prostate histology . Prostate. 28:1996;84-88.
21. Tubaro A., Paradiso G.G., Vincenti C., et al. The impact of transurethral microwave thermotherapy on prostate blood perfusion. A colour flow Doppler sonography study. Proceedings of the Congress of the Societe Internationale d'Urologie. 1994;243 SIU, Sydney.
22. Larson T.R., Collins J.M. Increased prostatic blood flow in response to microwave thermal treatment preliminary findings in two patients with benign prostatic hyperplasia . Urology. 46:1995;584-590.